Long-Term Immunosuppression After Solitary Islet Transplantation Is Associated With Preserved C-Peptide Secretion for More Than a Decade-Reference-Cited by-同舟云学术

Long-Term Immunosuppression After Solitary Islet Transplantation Is Associated With Preserved C-Peptide Secretion for More Than a Decade

Published:2015-07-16 Issue:11 Volume:15 Page:2995-3001
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Blau J. E.¹,Abegg M. R.¹,Flegel W. A.²,Zhao X.¹,Harlan D. M.³,Rother K. I.¹

Affiliation:

1. Diabetes, Endocrinology, and Obesity Branch; NIDDK National Institutes of Health; Bethesda MD

2. Department of Transfusion Medicine; NIH Clinical Center National Institutes of Health; Bethesda MD

3. Division of Diabetes, Endocrinology, and Nutrition Diabetes Center of Excellence, Department of Internal Medicine; University of Massachusetts Medical School; North Worcester MA

Funder

Intramural Research Program

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference24 articles.

1. Five-year follow-up after clinical islet transplantation;Ryan;Diabetes,2005

2. Improvement in outcomes of clinical islet transplantation: 1999-2010;Barton;Diabetes Care,2012

3. Immune antibody monitoring predicts outcome in islet transplantation;Shapiro;Diabetes,2013

4. Treating diabetes with islet transplantation: Lessons from the past decade in Lille;Vantyghem;Diabetes Metab,2014

5. Islet transplantation in type 1 diabetes: Ongoing challenges, refined procedures, and long-term outcome;Shapiro;Rev Diabet Stud,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic applications of CRISPR-Cas9 in diabetes mellitus: a perspective review;Minerva Biotechnology and Biomolecular Research;2024-01

2. A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-31

3. Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes;Cell Stem Cell;2023-05

4. THE VALUE OF COMBINED DETECTION OF GLYCOSYLATED HEMOGLOBIN, C-PEPTIDE AND INSULIN IN EVALUATING DISEASE PROGRESSION OF ELDERLY TYPE 2 DIABETES MELLITUS PATIENTS;ACTA MEDICA MEDITERR;2022

5. Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network;American Journal of Transplantation;2021-07-29